{
  "analysis_mode": "HISTORICAL_ONLY",
  "symbol": "VAL.L",
  "generated_at": "2026-01-13T15:02:22.628331Z",
  "top_card": {
    "ticker": "VAL.L",
    "company_name": "ValiRx plc",
    "sector": "Healthcare",
    "market_cap_gbp": 2722072,
    "days_active": 53,
    "apex_score_100": 55,
    "confidence_score_100": 60,
    "ai_final_score_25": 15,
    "ai_strength": "STRONG",
    "timing_regime": "CONFIRMED",
    "action": "HOLD/WATCH",
    "thesis_one_liner": "HOLD/WATCH - CONFIRMED timing with 55/100 opportunity score"
  },
  "enrichment": {
    "company_info": {
      "name": "ValiRx plc",
      "sector": "Healthcare",
      "industry": "Biotechnology",
      "exchange": "LSE",
      "market": "AIM",
      "currency": "GBP",
      "risk_tier": "High Risk",
      "current_market_cap": 2722072,
      "current_close_price": 0.3425
    },
    "basics": {
      "ticker": "VAL.L",
      "current_price": 0.3425,
      "ath": 73.0,
      "atl": 0.22,
      "ath_date": "2020-09-28",
      "atl_date": "2025-10-30",
      "week_52_high": 0.95,
      "week_52_low": 0.22,
      "week_52_high_date": "2025-01-16",
      "week_52_low_date": "2025-10-30",
      "drawdown_from_ath_pct": 99.53,
      "data_start": "2020-01-02",
      "data_end": "2026-01-13",
      "total_bars": 1523
    },
    "latest_signal": {
      "date": "2025-11-21",
      "scan_date": "2026-01-12",
      "signal_type": "DEEP CRASH BOTTOM",
      "signal_color": "GREEN",
      "price": 0.225,
      "drawdown_pct": 87.14,
      "ai_score": 12.0,
      "rsi": 0.0,
      "cycle_position": 0.0094,
      "holding_period_days": 53,
      "current_pnl_pct": 52.22,
      "rally_state": "rallying",
      "distance_from_high_pct": -18.45,
      "Rally_Count": 1,
      "days_since_last_high": 7,
      "last_high_date": "2026-01-06",
      "lock_in_reached": true,
      "lock_in_date": "2025-12-17",
      "best_rally_pct": 86.67
    },
    "best_historical_signal": {
      "signal_date": "2024-05-15",
      "signal_type": "DEEP CRASH BOTTOM",
      "signal_color": "GREEN",
      "entry_price": 1.9,
      "peak_price": 4.489,
      "peak_date": "2024-05-21",
      "rally_pct": 136.26,
      "days_to_peak": 6,
      "ai_score": 15.0
    },
    "all_historical_signals": [
      {
        "signal_id": "VAL.L_2022-06-30",
        "signal_date": "2022-06-30",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 10.75,
        "current_price": 0.365,
        "current_return_pct": -96.6,
        "best_rally_pct": 86.05,
        "best_rally_date": "2022-09-12",
        "rally_state": "accumulating",
        "Rally_Count": 5,
        "distance_from_high_pct": -98.17,
        "days_since_last_high": 26,
        "lock_in_reached": true,
        "age_days": 1292,
        "status": "historical"
      },
      {
        "signal_id": "VAL.L_2022-07-01",
        "signal_date": "2022-07-01",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 10.5,
        "current_price": 0.365,
        "current_return_pct": -96.52,
        "best_rally_pct": 90.48,
        "best_rally_date": "2022-09-12",
        "rally_state": "accumulating",
        "Rally_Count": 5,
        "distance_from_high_pct": -98.17,
        "days_since_last_high": 26,
        "lock_in_reached": true,
        "age_days": 1291,
        "status": "historical"
      },
      {
        "signal_id": "VAL.L_2022-07-04",
        "signal_date": "2022-07-04",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 10.75,
        "current_price": 0.365,
        "current_return_pct": -96.6,
        "best_rally_pct": 86.05,
        "best_rally_date": "2022-09-12",
        "rally_state": "accumulating",
        "Rally_Count": 5,
        "distance_from_high_pct": -98.17,
        "days_since_last_high": 26,
        "lock_in_reached": true,
        "age_days": 1288,
        "status": "historical"
      },
      {
        "signal_id": "VAL.L_2022-07-05",
        "signal_date": "2022-07-05",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 10.9,
        "current_price": 0.365,
        "current_return_pct": -96.65,
        "best_rally_pct": 83.49,
        "best_rally_date": "2022-09-12",
        "rally_state": "accumulating",
        "Rally_Count": 7,
        "distance_from_high_pct": -98.17,
        "days_since_last_high": 26,
        "lock_in_reached": true,
        "age_days": 1287,
        "status": "historical"
      },
      {
        "signal_id": "VAL.L_2022-07-08",
        "signal_date": "2022-07-08",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 10.75,
        "current_price": 0.365,
        "current_return_pct": -96.6,
        "best_rally_pct": 86.05,
        "best_rally_date": "2022-09-12",
        "rally_state": "accumulating",
        "Rally_Count": 5,
        "distance_from_high_pct": -98.17,
        "days_since_last_high": 26,
        "lock_in_reached": true,
        "age_days": 1284,
        "status": "historical"
      },
      {
        "signal_id": "VAL.L_2024-05-15",
        "signal_date": "2024-05-15",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 1.9,
        "current_price": 0.365,
        "current_return_pct": -80.79,
        "best_rally_pct": 110.53,
        "best_rally_date": "2024-05-20",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -90.87,
        "days_since_last_high": 26,
        "lock_in_reached": true,
        "age_days": 607,
        "status": "historical"
      },
      {
        "signal_id": "VAL.L_2024-05-16",
        "signal_date": "2024-05-16",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 1.9,
        "current_price": 0.365,
        "current_return_pct": -80.79,
        "best_rally_pct": 110.53,
        "best_rally_date": "2024-05-20",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -90.87,
        "days_since_last_high": 26,
        "lock_in_reached": true,
        "age_days": 606,
        "status": "historical"
      },
      {
        "signal_id": "VAL.L_2024-08-23",
        "signal_date": "2024-08-23",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 2.25,
        "current_price": 0.365,
        "current_return_pct": -83.78,
        "best_rally_pct": 6.67,
        "best_rally_date": "2024-08-27",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": -84.79,
        "days_since_last_high": 26,
        "lock_in_reached": true,
        "age_days": 507,
        "status": "historical"
      },
      {
        "signal_id": "VAL.L_2024-08-29",
        "signal_date": "2024-08-29",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 2.2,
        "current_price": 0.365,
        "current_return_pct": -83.41,
        "best_rally_pct": -2.27,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": 0.0,
        "days_since_last_high": 26,
        "lock_in_reached": true,
        "age_days": 501,
        "status": "historical"
      },
      {
        "signal_id": "VAL.L_2024-08-30",
        "signal_date": "2024-08-30",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 2.05,
        "current_price": 0.365,
        "current_return_pct": -82.2,
        "best_rally_pct": 4.88,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": -83.02,
        "days_since_last_high": 26,
        "lock_in_reached": true,
        "age_days": 500,
        "status": "historical"
      },
      {
        "signal_id": "VAL.L_2024-09-04",
        "signal_date": "2024-09-04",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 2.05,
        "current_price": 0.365,
        "current_return_pct": -82.2,
        "best_rally_pct": 4.88,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": -83.02,
        "days_since_last_high": 26,
        "lock_in_reached": true,
        "age_days": 495,
        "status": "historical"
      },
      {
        "signal_id": "VAL.L_2024-09-17",
        "signal_date": "2024-09-17",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 1.825,
        "current_price": 0.365,
        "current_return_pct": -80.0,
        "best_rally_pct": 17.81,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -83.02,
        "days_since_last_high": 26,
        "lock_in_reached": true,
        "age_days": 482,
        "status": "historical"
      },
      {
        "signal_id": "VAL.L_2024-09-18",
        "signal_date": "2024-09-18",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 1.65,
        "current_price": 0.365,
        "current_return_pct": -77.88,
        "best_rally_pct": 30.3,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -83.02,
        "days_since_last_high": 26,
        "lock_in_reached": true,
        "age_days": 481,
        "status": "historical"
      },
      {
        "signal_id": "VAL.L_2024-09-26",
        "signal_date": "2024-09-26",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 1.7,
        "current_price": 0.365,
        "current_return_pct": -78.53,
        "best_rally_pct": 26.47,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -83.02,
        "days_since_last_high": 26,
        "lock_in_reached": true,
        "age_days": 473,
        "status": "historical"
      },
      {
        "signal_id": "VAL.L_2024-09-27",
        "signal_date": "2024-09-27",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 1.45,
        "current_price": 0.365,
        "current_return_pct": -74.83,
        "best_rally_pct": 48.28,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -83.02,
        "days_since_last_high": 26,
        "lock_in_reached": true,
        "age_days": 472,
        "status": "historical"
      },
      {
        "signal_id": "VAL.L_2024-10-03",
        "signal_date": "2024-10-03",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 1.35,
        "current_price": 0.365,
        "current_return_pct": -72.96,
        "best_rally_pct": 59.26,
        "best_rally_date": "2024-10-21",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -83.02,
        "days_since_last_high": 26,
        "lock_in_reached": true,
        "age_days": 466,
        "status": "historical"
      },
      {
        "signal_id": "VAL.L_2024-12-09",
        "signal_date": "2024-12-09",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 0.775,
        "current_price": 0.365,
        "current_return_pct": -52.9,
        "best_rally_pct": 12.9,
        "best_rally_date": "2025-01-16",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -58.29,
        "days_since_last_high": 26,
        "lock_in_reached": true,
        "age_days": 399,
        "status": "historical"
      },
      {
        "signal_id": "VAL.L_2024-12-10",
        "signal_date": "2024-12-10",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 0.775,
        "current_price": 0.365,
        "current_return_pct": -52.9,
        "best_rally_pct": 12.9,
        "best_rally_date": "2025-01-16",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -58.29,
        "days_since_last_high": 26,
        "lock_in_reached": true,
        "age_days": 398,
        "status": "historical"
      },
      {
        "signal_id": "VAL.L_2024-12-11",
        "signal_date": "2024-12-11",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.8,
        "current_price": 0.365,
        "current_return_pct": -54.37,
        "best_rally_pct": 9.37,
        "best_rally_date": "2025-01-16",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": -58.29,
        "days_since_last_high": 26,
        "lock_in_reached": true,
        "age_days": 397,
        "status": "historical"
      },
      {
        "signal_id": "VAL.L_2024-12-13",
        "signal_date": "2024-12-13",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.775,
        "current_price": 0.365,
        "current_return_pct": -52.9,
        "best_rally_pct": 12.9,
        "best_rally_date": "2025-01-16",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -58.29,
        "days_since_last_high": 26,
        "lock_in_reached": true,
        "age_days": 395,
        "status": "historical"
      },
      {
        "signal_id": "VAL.L_2024-12-18",
        "signal_date": "2024-12-18",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.725,
        "current_price": 0.365,
        "current_return_pct": -49.66,
        "best_rally_pct": 20.69,
        "best_rally_date": "2025-01-16",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -58.29,
        "days_since_last_high": 26,
        "lock_in_reached": true,
        "age_days": 390,
        "status": "historical"
      },
      {
        "signal_id": "VAL.L_2024-12-27",
        "signal_date": "2024-12-27",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.675,
        "current_price": 0.365,
        "current_return_pct": -45.93,
        "best_rally_pct": 29.63,
        "best_rally_date": "2025-01-16",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -58.29,
        "days_since_last_high": 26,
        "lock_in_reached": true,
        "age_days": 381,
        "status": "historical"
      },
      {
        "signal_id": "VAL.L_2024-12-30",
        "signal_date": "2024-12-30",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.625,
        "current_price": 0.365,
        "current_return_pct": -41.6,
        "best_rally_pct": 40.0,
        "best_rally_date": "2025-01-16",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -58.29,
        "days_since_last_high": 26,
        "lock_in_reached": true,
        "age_days": 378,
        "status": "historical"
      },
      {
        "signal_id": "VAL.L_2025-01-03",
        "signal_date": "2025-01-03",
        "signal_type": "ENHANCED CRASH CRASH-ACCUM COMBO",
        "signal_color": "PURPLE",
        "entry_price": 0.7,
        "current_price": 0.365,
        "current_return_pct": -47.86,
        "best_rally_pct": 25.0,
        "best_rally_date": "2025-01-16",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -58.29,
        "days_since_last_high": 26,
        "lock_in_reached": true,
        "age_days": 374,
        "status": "historical"
      },
      {
        "signal_id": "VAL.L_2025-02-13",
        "signal_date": "2025-02-13",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.625,
        "current_price": 0.365,
        "current_return_pct": -41.6,
        "best_rally_pct": 20.0,
        "best_rally_date": "2025-09-08",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -51.33,
        "days_since_last_high": 26,
        "lock_in_reached": true,
        "age_days": 333,
        "status": "historical"
      },
      {
        "signal_id": "VAL.L_2025-02-24",
        "signal_date": "2025-02-24",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 0.575,
        "current_price": 0.365,
        "current_return_pct": -36.52,
        "best_rally_pct": 30.43,
        "best_rally_date": "2025-09-08",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -51.33,
        "days_since_last_high": 26,
        "lock_in_reached": true,
        "age_days": 322,
        "status": "historical"
      },
      {
        "signal_id": "VAL.L_2025-03-24",
        "signal_date": "2025-03-24",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 0.575,
        "current_price": 0.365,
        "current_return_pct": -36.52,
        "best_rally_pct": 30.43,
        "best_rally_date": "2025-09-08",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -51.33,
        "days_since_last_high": 26,
        "lock_in_reached": true,
        "age_days": 294,
        "status": "historical"
      },
      {
        "signal_id": "VAL.L_2025-03-27",
        "signal_date": "2025-03-27",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.525,
        "current_price": 0.365,
        "current_return_pct": -30.48,
        "best_rally_pct": 42.86,
        "best_rally_date": "2025-09-08",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -51.33,
        "days_since_last_high": 26,
        "lock_in_reached": true,
        "age_days": 291,
        "status": "historical"
      },
      {
        "signal_id": "VAL.L_2025-03-28",
        "signal_date": "2025-03-28",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.5,
        "current_price": 0.365,
        "current_return_pct": -27.0,
        "best_rally_pct": 50.0,
        "best_rally_date": "2025-09-08",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -51.33,
        "days_since_last_high": 26,
        "lock_in_reached": true,
        "age_days": 290,
        "status": "historical"
      },
      {
        "signal_id": "VAL.L_2025-04-03",
        "signal_date": "2025-04-03",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.45,
        "current_price": 0.365,
        "current_return_pct": -18.89,
        "best_rally_pct": 66.67,
        "best_rally_date": "2025-09-08",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -51.33,
        "days_since_last_high": 26,
        "lock_in_reached": true,
        "age_days": 284,
        "status": "historical"
      },
      {
        "signal_id": "VAL.L_2025-04-04",
        "signal_date": "2025-04-04",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 0.415,
        "current_price": 0.365,
        "current_return_pct": -12.05,
        "best_rally_pct": 80.72,
        "best_rally_date": "2025-09-08",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -51.33,
        "days_since_last_high": 26,
        "lock_in_reached": true,
        "age_days": 283,
        "status": "historical"
      },
      {
        "signal_id": "VAL.L_2025-04-07",
        "signal_date": "2025-04-07",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 0.425,
        "current_price": 0.365,
        "current_return_pct": -14.12,
        "best_rally_pct": 76.47,
        "best_rally_date": "2025-09-08",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -51.33,
        "days_since_last_high": 26,
        "lock_in_reached": true,
        "age_days": 280,
        "status": "historical"
      },
      {
        "signal_id": "VAL.L_2025-10-30",
        "signal_date": "2025-10-30",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.25,
        "current_price": 0.365,
        "current_return_pct": 46.0,
        "best_rally_pct": 68.0,
        "best_rally_date": "2025-12-17",
        "rally_state": "rallying",
        "Rally_Count": 1,
        "distance_from_high_pct": -13.1,
        "days_since_last_high": 26,
        "lock_in_reached": true,
        "age_days": 74,
        "status": "historical"
      },
      {
        "signal_id": "VAL.L_2025-10-31",
        "signal_date": "2025-10-31",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.25,
        "current_price": 0.365,
        "current_return_pct": 46.0,
        "best_rally_pct": 68.0,
        "best_rally_date": "2025-12-17",
        "rally_state": "rallying",
        "Rally_Count": 1,
        "distance_from_high_pct": -13.1,
        "days_since_last_high": 26,
        "lock_in_reached": true,
        "age_days": 73,
        "status": "historical"
      },
      {
        "signal_id": "VAL.L_2025-11-03",
        "signal_date": "2025-11-03",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.245,
        "current_price": 0.365,
        "current_return_pct": 48.98,
        "best_rally_pct": 71.43,
        "best_rally_date": "2025-12-17",
        "rally_state": "rallying",
        "Rally_Count": 1,
        "distance_from_high_pct": -13.1,
        "days_since_last_high": 26,
        "lock_in_reached": true,
        "age_days": 70,
        "status": "historical"
      },
      {
        "signal_id": "VAL.L_2025-11-04",
        "signal_date": "2025-11-04",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.24,
        "current_price": 0.365,
        "current_return_pct": 52.08,
        "best_rally_pct": 75.0,
        "best_rally_date": "2025-12-17",
        "rally_state": "rallying",
        "Rally_Count": 1,
        "distance_from_high_pct": -13.1,
        "days_since_last_high": 26,
        "lock_in_reached": true,
        "age_days": 69,
        "status": "historical"
      },
      {
        "signal_id": "VAL.L_2025-11-21",
        "signal_date": "2025-11-21",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.225,
        "current_price": 0.3425,
        "current_return_pct": 52.22,
        "best_rally_pct": 86.67,
        "best_rally_date": "2025-12-17",
        "rally_state": "rallying",
        "Rally_Count": 1,
        "distance_from_high_pct": -18.45,
        "days_since_last_high": 7,
        "lock_in_reached": true,
        "age_days": 53,
        "status": "active"
      }
    ],
    "stats": {
      "total_signals": 37,
      "win_rate_pct": 100.0,
      "avg_rally_pct": 65.16,
      "median_rally_pct": 63.24,
      "best_rally_pct": 136.26,
      "worst_rally_pct": 7.59
    },
    "splits": [],
    "split_risk": {
      "split_detected": false,
      "risk_level": "NONE",
      "confidence": "HIGH"
    },
    "data_quality": {
      "price_reliability": "RELIABLE",
      "pnl_reliability": "RELIABLE",
      "overall_confidence": "HIGH"
    },
    "risk_flags": [
      "EXTREME_DRAWDOWN",
      "FREQUENT_CRASHES"
    ],
    "last_updated": "2026-01-13 14:05:59 UTC"
  },
  "decision_summary": {
    "why_it_matters": [
      "APEX 55/100 indicates strong opportunity quality",
      "Timing regime: CONFIRMED",
      "Historical profile: 1 rallies, 87% best run"
    ],
    "main_risk": "Confidence 60/100 - full data loaded",
    "watch_next": [
      "RNS catalysts (funding/operational updates)",
      "Volume expansion confirmation",
      "Timing regime change signals"
    ]
  },
  "triangulation": {
    "rns": {
      "has_data": true,
      "ticker": "VAL.L",
      "latest": [
        {
          "title": "Replacement: Evaluation and Transfer Agreement",
          "announcement_date": "9th Jan 2026",
          "release_time": "3:45 pm",
          "source": "RNS",
          "content": "Today 15:45\nRNS Number : 3936O\nValiRx PLC\n09 January 2026\n9 January 2026\nThe following amendment has been made to the 'New Evaluation and Material Transfer Agreement' announcement released on 9 January 2026 at 7:00 a.m. under RNS No 2552O.\nThe announcement has been amended to 'the Company has an option to license the Evaluation Results into NewCo for a pre-agreed equity holding.' in the third paragraph of the announcement.\nAll other details remain unchanged.\nThe full amended text is shown below.\nValiRx PLC\n(\"ValiRx\" or the \"Company\")\nNew Evaluation and Material Transfer Agreement\nValiRx plc (the \"Company\") (AIM: VAL), a life sciences company focusing on early-stage cancer therapeutics and women's health and The Royal Institute for the Advancement of Learning/McGill University (\"McGill\"), a Canadian based University, and The Institute for Research in Immunology, and Cancer - Commercialization of Research (\"IRICoR\"), a Canadian based non-profit organisation, have entered into a nine-month, Evaluation and Material transfer agreement (the \"Agreement\").\nUnder the new format Agreement with McGill and IRICoR (the \"Institutions\"),\ntarget engagement and potency of a second generation, orally available, RNA Helicase inhibitor will be established by the Company's wholly owned subsidiary, Inaphaea Biolabs Ltd (\"Inaphaea\").\nDuring the evaluation period, any results generated will be owned by ValiRx (the \"Evaluation Results\").\nIRICoR will establish a Canadian registered, wholly owned, subsidiary\n(\"NewCo\") for the purpose of commercialising the Evaluation Results and Background Intellectual Property and grant\nNewCo an\nexclusive, worldwide sub-licensable license to any Background Intellectual Property.\nOn completion of the Evaluation Results, the Company has an option to license the Evaluation Results into NewCo for a pre-agreed equity holding.\nNewCo will seek external non-dilutive and dilutive funding and ValiRx (and potentially other investors arranged by ValiRx) may, subject to availability of funds, provide up to \u00a32 million of seed funding (\"Seed Funding\"). Any such Seed Funding would be provided in tranches in line with the cash requirements, in exchange for further equity under a development plan provided by the Company. Funding other than the Seed Funding shall dilute all shares\npari passu\n.\nAlternatively, if within 30 days of the completion of the evaluation, ValiRx elects not to proceed with the license for equity, the rights to the Evaluation Results will be assigned to the Institutions and, if the Institutions then\nout-license, sell or otherwise commercialise the Technology\nat any time following the evaluation period, ValiRx will be entitled to a cash payment of 1.5x its total investment (estimated at no more than \u00a3150,000) from IRICoR.\nMark Eccleston, CEO of ValiRx commented\n\"I am excited to announce this Evaluation Agreement with McGill and IRICoR, who have already carried out extensive development work on this high quality, second-generation RNA Helicase Inhibitor making it one of the latest stage assets we've been able to access. We have performed extensive due diligence on the technical, clinical and commercial positioning of this asset and see significant opportunities in the human and veterinary health markets. The structure of the agreement reflects the quality and stage of the asset, the value Inaphaea can bring, and a desire from all parties to secure external funding to support rapid translation to a clinical candidate.\"\nMartin Gouldstone, Chairman of ValiRx\ncommented\n\"This is an important agreement with McGill and IRICoR as it\nreflects ValiRx's commitment to identifying, developing and partnering high quality, later stage assets that are closer to the clinic and therefore commercialisation.\nThis new style agreement envisages additional, external, investment into the NewCo set up to commercialise the results alongside future investments from ValiRx. This approach to diluting individual assets rather than ValiRx plc is designed to maximise the use and impact of our funding.\"\nClaude Larose, VP Business Development at IRICoR commented \"\nWe are delighted to be working with Inaphaea ValiRx and to commercialise our RNA Helicase asset\n.\nIn parallel, we will set up a commercial entity with a strategic objective to maximise the clinical and commercial value of the Evaluation Results and original data and look forward to working with ValiRx and their appointed directors to secure additional investment. For clinical development we envisage the NewCo may (1) out-license the Technology and Background Intellectual Property to a biopharmaceutical partner, (2) raise additional institutional capital to independently advance the program into clinical studies, or (3) pursue a strategic transaction, including a potential sale or merger. This structure provides multiple pathways to value creation while maintaining alignment between ValiRx, McGill and IRICoR\n.\"\nThe information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018 (\"UK MAR\"). The Directors of the Company take responsibility for this announcement.\n*** ENDS ***\nEngage with the ValiRx management team directly by asking questions, watching video\nsummaries and seeing what other shareholders have to say. Navigate to our Interactive Investor\nhub here:\nhttps://valirx.com/s/cc8ef3\nFor more information, please contact:\nInvestor questions on this announcement\nWe encourage all investors to share questions on this announcement via our investor hub\nhttps://valirx.com/link/exkQJy\nValiRx plc\nDr Mark Eccleston, CEO\nTel: +44 115 784 0025\nwww.valirx.com\nMark.Eccleston@valirx.com\nCairn Financial Advisers LLP (Nominated Adviser)\nLiam Murray / Ludovico Lazzaretti\nTel: +44 (0) 20 7213 0880\nShard Capital Partners LLP (Sole Broker)\nDamon Heath\nTel: +44 (0) 20 7186 9000\nV Formation (Public Relations)\nLucy Wharton - Senior PR Executive\nSue Carr - Director\n+44 (0) 115 787 0206\nwww.vformation.biz\nlucy@vformation.biz\nsue@vformation.biz\nSubscribe to our news alert service:\nhttps://valirx.com/s/f298d1\nNotes for Editors\nAbout ValiRx\nValiRx is a life science company focused on early-stage cancer therapeutics and women's health, accelerating the translation of innovative science into impactful medicines to improve patient lives.\nValiRx provides the scientific, financial, and commercial framework for enabling rapid translation of innovative science into clinical development.\nUsing its extensive and proven experience in research and drug development, the team at ValiRx selects and incubates promising novel drug candidates and guides them through an optimised process of development, from pre-clinical studies to clinic and investor-ready assets.\nValiRx connects diverse disciplines across scientific, technical, and commercial domains, with the aim of achieving a more streamlined, less costly, drug development process. The team works closely with carefully selected collaborators and leverages the combined expertise required for science to advance.\nLead candidates from ValiRx's portfolio are outlicensed or partnered with investors through ValiRx subsidiary companies for further clinical development and commercialisation.\nValiRx listed on the AIM Market of the London Stock Exchange in October 2006 and trades under the ticker symbol: VAL.\nFor further information, visit:\nwww.valirx.com\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nAGRZZGGMKLVGVZM"
        },
        {
          "title": "New Evaluation and Material Transfer Agreement",
          "announcement_date": "9th Jan 2026",
          "release_time": "7:00 am",
          "source": "RNS",
          "content": "Today 07:00\nRNS Number : 2552O\nValiRx PLC\n09 January 2026\n9 January 2026\nValiRx PLC\n(\"ValiRx\" or the \"Company\")\nNew Evaluation and Material Transfer Agreement\nValiRx plc (the \"Company\") (AIM: VAL), a life sciences company focusing on early-stage cancer therapeutics and women's health and The Royal Institute for the Advancement of Learning/McGill University (\"McGill\"), a Canadian based University, and The Institute for Research in Immunology, and Cancer - Commercialization of Research (\"IRICoR\"), a Canadian based non-profit organisation, have entered into a nine-month, Evaluation and Material transfer agreement (the \"Agreement\").\nUnder the new format Agreement with McGill and IRICoR (the \"Institutions\"),\ntarget engagement and potency of a second generation, orally available, RNA Helicase inhibitor will be established by the Company's wholly owned subsidiary, Inaphaea Biolabs Ltd (\"Inaphaea\").\nDuring the evaluation period, any results generated will be owned by ValiRx (the \"Evaluation Results\").\nIRICoR will establish a Canadian registered, wholly owned, subsidiary\n(\"NewCo\") for the purpose of commercialising the Evaluation Results and Background Intellectual Property and grant\nNewCo an\nexclusive, worldwide sub-licensable license to any Background Intellectual Property.\nOn completion of the Evaluation Results, the Company has an option to license the Evaluation Results into NewCo for a 15% equity holding under pre-agreed terms.\nNewCo will seek external non-dilutive and dilutive funding and ValiRx (and potentially other investors arranged by ValiRx) may, subject to availability of funds, provide up to \u00a32 million of seed funding (\"Seed Funding\"). Any such Seed Funding would be provided in tranches in line with the cash requirements, in exchange for further equity under a development plan provided by the Company. Funding other than the Seed Funding shall dilute all shares\npari passu\n.\nAlternatively, if within 30 days of the completion of the evaluation, ValiRx elects not to proceed with the license for equity, the rights to the Evaluation Results will be assigned to the Institutions and, if the Institutions then\nout-license, sell or otherwise commercialise the Technology\nat any time following the evaluation period, ValiRx will be entitled to a cash payment of 1.5x its total investment (estimated at no more than \u00a3150,000) from IRICoR.\nMark Eccleston, CEO of ValiRx commented\n\"I am excited to announce this Evaluation Agreement with McGill and IRICoR, who have already carried out extensive development work on this high quality, second-generation RNA Helicase Inhibitor making it one of the latest stage assets we've been able to access. We have performed extensive due diligence on the technical, clinical and commercial positioning of this asset and see significant opportunities in the human and veterinary health markets. The structure of the agreement reflects the quality and stage of the asset, the value Inaphaea can bring, and a desire from all parties to secure external funding to support rapid translation to a clinical candidate.\"\nMartin Gouldstone, Chairman of ValiRx\ncommented\n\"This is an important agreement with McGill and IRICoR as it\nreflects ValiRx's commitment to identifying, developing and partnering high quality, later stage assets that are closer to the clinic and therefore commercialisation.\nThis new style agreement envisages additional, external, investment into the NewCo set up to commercialise the results alongside future investments from ValiRx. This approach to diluting individual assets rather than ValiRx plc is designed to maximise the use and impact of our funding.\"\nClaude Larose, VP Business Development at IRICoR commented \"\nWe are delighted to be working with Inaphaea ValiRx and to commercialise our RNA Helicase asset\n.\nIn parallel, we will set up a commercial entity with a strategic objective to maximise the clinical and commercial value of the Evaluation Results and original data and look forward to working with ValiRx and their appointed directors to secure additional investment. For clinical development we envisage the NewCo may (1) out-license the Technology and Background Intellectual Property to a biopharmaceutical partner, (2) raise additional institutional capital to independently advance the program into clinical studies, or (3) pursue a strategic transaction, including a potential sale or merger. This structure provides multiple pathways to value creation while maintaining alignment between ValiRx, McGill and IRICoR\n.\"\nThe information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018 (\"UK MAR\"). The Directors of the Company take responsibility for this announcement.\n*** ENDS ***\nEngage with the ValiRx management team directly by asking questions, watching video\nsummaries and seeing what other shareholders have to say. Navigate to our Interactive Investor\nhub here:\nhttps://valirx.com/s/cc8ef3\nFor more information, please contact:\nInvestor questions on this announcement\nWe encourage all investors to share questions on this announcement via our investor hub\nhttps://valirx.com/link/exkQJy\nValiRx plc\nDr Mark Eccleston, CEO\nTel: +44 115 784 0025\nwww.valirx.com\nMark.Eccleston@valirx.com\nCairn Financial Advisers LLP (Nominated Adviser)\nLiam Murray / Ludovico Lazzaretti\nTel: +44 (0) 20 7213 0880\nShard Capital Partners LLP (Sole Broker)\nDamon Heath\nTel: +44 (0) 20 7186 9000\nV Formation (Public Relations)\nLucy Wharton - Senior PR Executive\nSue Carr - Director\n+44 (0) 115 787 0206\nwww.vformation.biz\nlucy@vformation.biz\nsue@vformation.biz\nSubscribe to our news alert service:\nhttps://valirx.com/s/f298d1\nNotes for Editors\nAbout ValiRx\nValiRx is a life science company focused on early-stage cancer therapeutics and women's health, accelerating the translation of innovative science into impactful medicines to improve patient lives.\nValiRx provides the scientific, financial, and commercial framework for enabling rapid translation of innovative science into clinical development.\nUsing its extensive and proven experience in research and drug development, the team at ValiRx selects and incubates promising novel drug candidates and guides them through an optimised process of development, from pre-clinical studies to clinic and investor-ready assets.\nValiRx connects diverse disciplines across scientific, technical, and commercial domains, with the aim of achieving a more streamlined, less costly, drug development process. The team works closely with carefully selected collaborators and leverages the combined expertise required for science to advance.\nLead candidates from ValiRx's portfolio are outlicensed or partnered with investors through ValiRx subsidiary companies for further clinical development and commercialisation.\nValiRx listed on the AIM Market of the London Stock Exchange in October 2006 and trades under the ticker symbol: VAL.\nFor further information, visit:\nwww.valirx.com\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nAGRGGGDBLBGDGLC"
        },
        {
          "title": "Holding(s) in Company",
          "announcement_date": "8th Jan 2026",
          "release_time": "1:00 pm",
          "source": "RNS",
          "content": "8 Jan 2026 13:00\nRNS Number : 2091O\nValiRx PLC\n08 January 2026\nTR-1: Standard form for notification of major holdings\n1. Issuer Details\nISIN\nGB00BLH13C52\nIssuer Name\nVALIRX PLC\nUK or Non-UK Issuer\nUK\n2. Reason for Notification\nAn acquisition or disposal of voting rights\n3. Details of person subject to the notification obligation\nName\nJaspal Singh\nCity of registered office (if applicable)\nWolverhampton\nCountry of registered office (if applicable)\nUnited Kingdom\n4. Details of the shareholder\nFull name of shareholder(s) if different from the person(s) subject to the notification obligation, above\nCity of registered office (if applicable)\nCountry of registered office (if applicable)\n5. Date on which the threshold was crossed or reached\n05-Jan-2026\n6. Date on which Issuer notified\n08-Jan-2026\n7. Total positions of person(s) subject to the notification obligation\n% of voting rights attached to shares (total of 8.A)\n% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)\nTotal of both in % (8.A + 8.B)\nTotal number of voting rights held in issuer\nResulting situation on the date on which threshold was crossed or reached\n2.960000\n0.000000\n2.960000\n22000000\nPosition of previous notification (if applicable)\n4.510000\n0.000000\n4.510000\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\n8A. Voting rights attached to shares\nClass/Type of shares ISIN code(if possible)\nNumber of direct voting rights (DTR5.1)\nNumber of indirect voting rights (DTR5.2.1)\n% of direct voting rights (DTR5.1)\n% of indirect voting rights (DTR5.2.1)\nGB00BLH13C52\n22000000\n2.960000\nSub Total 8.A\n22000000\n2.960000%\n8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))\nType of financial instrument\nExpiration date\nExercise/conversion period\nNumber of voting rights that may be acquired if the instrument is exercised/converted\n% of voting rights\nSub Total 8.B1\n8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))\nType of financial instrument\nExpiration date\nExercise/conversion period\nPhysical or cash settlement\nNumber of voting rights\n% of voting rights\nSub Total 8.B2\n9. Information in relation to the person subject to the notification obligation\n1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.\nUltimate controlling person\nName of controlled undertaking\n% of voting rights if it equals or is higher than the notifiable threshold\n% of voting rights through financial instruments if it equals or is higher than the notifiable threshold\nTotal of both if it equals or is higher than the notifiable threshold\n10. In case of proxy voting\nName of the proxy holder\nThe number and % of voting rights held\nThe date until which the voting rights will be held\n11. Additional Information\n12. Date of Completion\n08-Jan-2026\n13. Place Of Completion\nWOLVERHAMPTON\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nHOLUWUURNNUARAR"
        },
        {
          "title": "Holding(s) in Company",
          "announcement_date": "5th Dec 2025",
          "release_time": "10:56 am",
          "source": "RNS",
          "content": "5 Dec 2025 10:56\nRNS Number : 4689K\nValiRx PLC\n05 December 2025\nTR-1: S\ntandard form for notification of major holdings\nNOTIFICATION OF MAJOR HOLDINGS\n(to be sent to the relevant issuer\nand\nto the FCA in Microsoft Word format if possible)\ni\n1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached\nii\n:\nValiRx PLC\n1b. Please indicate if the issuer is a non-UK issuer\n(please mark with an \"X\" if appropriate)\nNon-UK issuer\n2. Reason for the notification\n(please mark the appropriate box or boxes with an \"X\")\nAn acquisition or disposal of voting rights\nX\nAn acquisition or disposal of financial instruments\nAn event changing the breakdown of voting rights\nOther (please specify) iii:\n3. Details of person subject to the notification obligation\niv\nName\nStephen Wolstenhulme\nCity and country of registered office (if applicable)\nUK\n4. Full name of shareholder(s)\n(if different from 3.)\nv\nName\nCity and country of registered office (if applicable)\n5. Date on which the threshold was crossed or reached\nvi\n:\n04/12/2025\n6.\nDate on which issuer notified (DD/MM/YYYY):\n05/12/2025\n7. Total positions of person(s) subject to the notification obligation\n% of voting rights attached to shares (total of 8. A)\n% of\nvoting rights through\nfinancial instruments(total of 8.B 1 + 8.B 2)\nTotal of both in % (8.A + 8.B)\nTotal number of voting rights held in issuer (8.A + 8.B)\nvii\nResulting situation on the date on which threshold was crossed or reached\nBelow 3%\nBelow 3%\nPosition of previous notification (if\napplicable)\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\nviii\nA: Voting rights attached to shares\nClass/type ofshares\nISIN code (if possible)\nNumber of voting rights\nix\n% of voting rights\nDirect\n(DTR5.1)\nIndirect\n(DTR5.2.1)\nDirect\n(DTR5.1)\nIndirect\n(DTR5.2.1)\nGB00BLH13C52\nSUBTOTAL 8. A\nBelow 3%\nBelow 3%\nB 1: Financial Instruments according to DTR5.3.1R (1) (a)\nType of financial instrument\nExpirationdate\nx\nExercise/Conversion Period\nxi\nNumber of voting rights that may be acquired if the instrument is\nexercised/converted.\n% of voting rights\nSUBTOTAL 8. B 1\nB 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)\nType of financial instrument\nExpirationdate\nx\nExercise/Conversion Period\nxi\nPhysical or cash\nSettlement\nxii\nNumber of voting rights\n% of voting rights\nSUBTOTAL 8.B.2\n9. Information in relation to the person subject to the notification obligation\n(please mark the\napplicable box with an \"X\")\nPerson subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer\nxiii\nFull\nchain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity\n(please add additional rows as necessary)\nxiv\nX\nName\nxv\n% of voting rights if it equals or is higher than the notifiable threshold\n% of voting rights through financial instruments if it equals or is higher than the notifiable threshold\nTotal of both if it equals or is higher than the notifiable threshold\nStephen Wolstenhulme\nBelow 3%\nBelow 3%\nDaniele Wolstenhulme\nBelow 3%\nBelow 3%\nTotal\nBelow 3%\nBelow 3%\n10.\nIn case of proxy voting, please identify:\nName of the proxy holder\nThe number and % of voting rights held\nThe date until which the voting rights will be held\n11. Additional information\nxvi\nPlace of completion\nUK\nDate of completion\n05/12/2025\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nHOLUVVRRVVUURAA"
        },
        {
          "title": "Holding(s) in Company",
          "announcement_date": "24th Nov 2025",
          "release_time": "3:54 pm",
          "source": "RNS",
          "content": "24 Nov 2025 15:54\nRNS Number : 7861I\nValiRx PLC\n24 November 2025\nTR-1: S\ntandard form for notification of major holdings\nNOTIFICATION OF MAJOR HOLDINGS\n(to be sent to the relevant issuer\nand\nto the FCA in Microsoft Word format if possible)\ni\n1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached\nii\n:\nValiRx PLC\n1b. Please indicate if the issuer is a non-UK issuer\n(please mark with an \"X\" if appropriate)\nNon-UK issuer\n2. Reason for the notification\n(please mark the appropriate box or boxes with an \"X\")\nAn acquisition or disposal of voting rights\nX\nAn acquisition or disposal of financial instruments\nAn event changing the breakdown of voting rights\nX\nOther (please specify) iii:\n3. Details of person subject to the notification obligation\niv\nName\nStephen Wolstenhulme\nCity and country of registered office (if applicable)\nUK\n4. Full name of shareholder(s)\n(if different from 3.)\nv\nName\nCity and country of registered office (if applicable)\n5. Date on which the threshold was crossed or reached\nvi\n:\n21/11/2025\n6.\nDate on which issuer notified (DD/MM/YYYY):\n24/11/2025\n7. Total positions of person(s) subject to the notification obligation\n% of voting rights attached to shares (total of 8. A)\n% of\nvoting rights through\nfinancial instruments(total of 8.B 1 + 8.B 2)\nTotal of both in % (8.A + 8.B)\nTotal number of voting rights held in issuer (8.A + 8.B)\nvii\nResulting situation on the date on which threshold was crossed or reached\n3.25%\n3.25%\n24,150,000\nPosition of previous notification (if\napplicable)\n5.84%\n5.84%\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\nviii\nA: Voting rights attached to shares\nClass/type ofshares\nISIN code (if possible)\nNumber of voting rights\nix\n% of voting rights\nDirect\n(DTR5.1)\nIndirect\n(DTR5.2.1)\nDirect\n(DTR5.1)\nIndirect\n(DTR5.2.1)\nGB00BLH13C52\n13,475,000\n10,675,000\n1.81%\n1.44%\nSUBTOTAL 8. A\n24,150,000\n3.25%\nB 1: Financial Instruments according to DTR5.3.1R (1) (a)\nType of financial instrument\nExpirationdate\nx\nExercise/Conversion Period\nxi\nNumber of voting rights that may be acquired if the instrument is\nexercised/converted.\n% of voting rights\nSUBTOTAL 8. B 1\nB 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)\nType of financial instrument\nExpirationdate\nx\nExercise/Conversion Period\nxi\nPhysical or cash\nSettlement\nxii\nNumber of voting rights\n% of voting rights\nSUBTOTAL 8.B.2\n9. Information in relation to the person subject to the notification obligation\n(please mark the\napplicable box with an \"X\")\nPerson subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer\nxiii\nFull\nchain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity\n(please add additional rows as necessary)\nxiv\nX\nName\nxv\n% of voting rights if it equals or is higher than the notifiable threshold\n% of voting rights through financial instruments if it equals or is higher than the notifiable threshold\nTotal of both if it equals or is higher than the notifiable threshold\nStephen Wolstenhulme\n1.81%\n1.81%\nDaniele Wolstenhulme\n1.44%\n1.44%\nTotal\n3.25%\n3.25%\n10.\nIn case of proxy voting, please identify:\nName of the proxy holder\nThe number and % of voting rights held\nThe date until which the voting rights will be held\n11. Additional information\nxvi\nPlace of completion\nUK\nDate of completion\n24/11/2025\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nHOLUSVVRVUUAUAA"
        }
      ],
      "themes": [
        "funding",
        "drilling",
        "operations"
      ]
    },
    "social": {
      "has_data": true,
      "buzz_level": "HIGH",
      "post_count": 141,
      "sentiment_breakdown": {
        "positive": 0.0,
        "neutral": 100.0,
        "negative": 0.0
      }
    },
    "trends": {
      "has_data": true,
      "current_interest": 0,
      "momentum_score": 0,
      "trend_direction": "flat",
      "intelligence_signal": null
    },
    "volatility": {
      "atr_normalized": null,
      "stddev_20d": null
    },
    "risk_flags": {
      "split_risk_level": "NONE",
      "halt_risk": "NONE",
      "penny_stock_risk": "NONE"
    }
  },
  "ai_insights": {
    "available": false,
    "reason": "LLM module not loaded or analysis failed"
  },
  "crashdash": {
    "industry_intelligence": {
      "category": "INDUSTRIALS",
      "name": "Industrials",
      "icon": "\ud83c\udfed",
      "color": "#64748b",
      "crash_patterns": [
        "Order book decline or cancellations",
        "Margin compression (input costs)",
        "Cyclical demand weakness",
        "Project delays or overruns",
        "Working capital strain"
      ],
      "recovery_paths": [
        "Order book growth or new contracts",
        "Margin recovery (efficiency gains)",
        "Cyclical upturn (capex recovery)",
        "M&A consolidation",
        "Product innovation or new markets"
      ],
      "active_patterns": [],
      "relevant_rns_count": 0,
      "key_metrics": [
        "Order book value (forward revenue)",
        "Book-to-bill ratio",
        "Operating margin trends",
        "Working capital efficiency",
        "Capex cycles (customer industries)"
      ]
    },
    "panic_analysis": {
      "panic_score": 16,
      "signal": "NO_PANIC",
      "interpretation": "\u26aa Calm market - no crash signals detected",
      "breakdown": {
        "price_destruction": 0,
        "volume_death": 0,
        "social_silence": 6,
        "news_sentiment": 10
      },
      "is_opportunity": false,
      "opportunity_reason": "\ud83d\ude10 Normal market conditions - no crash signal"
    },
    "fear_vs_facts": {
      "fear_points": [],
      "facts_points": [],
      "verdict": "\u2696\ufe0f Mixed signals - Fear and facts balanced, wait for clarity"
    },
    "crashhunter_signals": [
      {
        "type": "CONFIRMED",
        "icon": "\u2705",
        "text": "Confirmed",
        "color": "#10b981"
      },
      {
        "type": "MODERATE_QUALITY",
        "icon": "\ud83c\udf1f",
        "text": "APEX 55",
        "color": "#3b82f6"
      }
    ],
    "catalyst_pipeline": [
      {
        "type": "rns",
        "date": "Unknown",
        "title": "Replacement: Evaluation and Transfer Agreement",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "Unknown",
        "title": "New Evaluation and Material Transfer Agreement",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "Unknown",
        "title": "Holding(s) in Company",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "Unknown",
        "title": "Holding(s) in Company",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "Unknown",
        "title": "Holding(s) in Company",
        "status": "published",
        "icon": "\ud83d\udce2"
      }
    ],
    "decision_matrix": {
      "decision": "AVOID",
      "reason": "\u274c HOLD/WATCH - timing CONFIRMED",
      "checklist": [
        {
          "criterion": "Panic Score",
          "value": "16/100",
          "pass": false,
          "icon": "\ud83d\udfe2"
        },
        {
          "criterion": "Timing Regime",
          "value": "CONFIRMED",
          "pass": true,
          "icon": "\u2705"
        },
        {
          "criterion": "APEX Quality",
          "value": "55/100",
          "pass": true,
          "icon": "\u2b50"
        },
        {
          "criterion": "Data Confidence",
          "value": "60/100",
          "pass": true,
          "icon": "\ud83c\udfaf"
        },
        {
          "criterion": "Industry Pattern",
          "value": "0 active",
          "pass": true,
          "icon": "\ud83c\udfed"
        }
      ],
      "pass_rate": "4/5"
    }
  },
  "scoring_breakdown": {
    "apex_factors": [
      "Technical quality: +15 (AI_Technical_Score=12.0/20)",
      "Drawdown reversion potential: +17 (Drawdown_Pct=87.1%)",
      "Volume confirmation: +10 (Relative_Volume=2.2)",
      "Pattern reliability: +5 (Rally_Count=1.0)",
      "Upside history: +8 (best_rally_pct=87%)"
    ],
    "technical_score": {
      "points": 15,
      "ai_score": 12.0,
      "reason": "AI Technical Score 12.0/20 translates to 15/25 points"
    },
    "drawdown_score": {
      "points": 17,
      "drawdown_pct": 87.14,
      "reason": "Drawdown of 87.1% gives 17/20 points"
    },
    "volume_score": {
      "points": 10,
      "rel_volume": 2.19,
      "reason": "Relative volume 2.19x gives 10 points"
    },
    "pattern_score": {
      "points": 5,
      "rally_count": 1.0,
      "reason": "1.0 historical rallies gives 5/15 points"
    },
    "upside_score": {
      "points": 8,
      "best_rally_pct": 86.67,
      "reason": "Best rally of 87% gives 8/20 points"
    },
    "penalties": {
      "total": 0,
      "items": []
    }
  },
  "reasons_buy_sell": {
    "reasons_to_buy": [
      {
        "reason": "Proven winner - previously hit lock-in target",
        "tag": "MED",
        "evidence": [
          "lock_in_reached=True"
        ]
      }
    ],
    "reasons_to_sell": []
  },
  "trade_plan": {
    "trader_plan": {
      "style": "Active trade",
      "action": "HOLD/WATCH",
      "sizing": "1-3% position based on conviction",
      "risk": "Stop below recent support / invalidation level",
      "profit_taking": "Scale out into strength: 25% @ +15%, 50% @ +50%, trail runner"
    },
    "investor_plan": {
      "allowed": false,
      "thesis_conditions": "Unlock after AI triangulation + CONFIRMED timing",
      "hold_window": "N/A",
      "risk_management": "N/A"
    }
  },
  "exhaustion": {
    "regime": "CONFIRMED",
    "run_multiple": 0.6,
    "current_run_pct": 52.22,
    "avg_historical_run_pct": 86.67
  },
  "history_snapshot": {
    "previous_report_date": null,
    "score_change": null,
    "confidence_change": null,
    "new_events_count": 0,
    "new_rns_titles": []
  },
  "commentary": {
    "executive_summary": "This report runs in HISTORICAL-ONLY mode: triangulation (RNS/social/trends) not loaded. The setup shows CONFIRMED timing with 55/100 APEX score. Historical data shows 1 rallies averaging 87% upside. Current position: +52.2%. Your edge comes from waiting for AI Engine confirmation instead of blind entry.",
    "bull_case": [
      "Limited upside case without catalysts"
    ],
    "bear_case": [
      "Monitor for breakdown signals"
    ],
    "timing_translation": "Momentum confirmed. This is the trade zone if thesis holds.",
    "confidence_explained": "Confidence 60/100 reflects full data quality with triangulation loaded."
  },
  "data_quality": {
    "sources_present": {
      "snapshot_json": false,
      "daily_enrichment_row": true,
      "historical_profile": false,
      "metadata": true,
      "triangulation_events": true,
      "ai_insights": false
    },
    "missing_data": [
      "AI insights from Groq LLM"
    ],
    "confidence_impact": "HIGH",
    "disclaimer": "Data provided as-is. Not financial advice. AIM micro-caps carry significant volatility risk."
  }
}